HMGN — Hemagen Diagnostics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual balance sheet for Hemagen Diagnostics, fiscal year end - September 30th, USD millions except per share, conversion factor applied.

	2008 September 30th	2009 September 30th	2010 September 30th	2011 September 30th	2012 September 30th
Period Length:	—	—	—	—	—
Source:	10KSB	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	0.099	0.156	0.152	0.214	0.066
Net Total Accounts Receivable
Net Total Receivables	1.08	0.84	0.88	0.615	0.588
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	3.52	2.82	2.77	2.45	2.09
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.696	0.599	0.526	0.387	0.282
Long Term Notes Receivable
Other Long Term Assets
Total Assets	4.76	3.72	3.37	2.89	2.44
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	5.74	1.45	1.17	1.53	1.95
Long Term Debt
Total Long Term Debt
Total Debt
Total Liabilities	5.86	5.5	5.22	5.58	6
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	-1.09	-1.78	-1.85	-2.69	-3.56
Total Liabilities & Shareholders' Equity	4.77	3.72	3.37	2.89	2.44
Total Common Shares Outstanding